Recurrent Bladder Carcinoma

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB00877Sirolimus0Completed1
DB10343Bacillus calmette-guerin substrain tice live antigen1Recruiting1
DB08875Cabozantinib1Recruiting1
DB01248Docetaxel1Recruiting1
DB00441Gemcitabine1Recruiting1
DB06186Ipilimumab1Recruiting1
DB09035Nivolumab1Recruiting1
DB09037Pembrolizumab1Recruiting2
DB15185Rasdegafusp alfa1Completed1
DB06176Romidepsin1Active Not Recruiting1
DB14797SEphB4-HSA1Not Yet Recruiting1
DB14797SEphB4-HSA1Recruiting1
DB00020Sargramostim1Terminated1
DB00877Sirolimus1Completed1
DB14547Chloride ion1 / 2Completed1
DB00515Cisplatin1 / 2Completed1
DB08871Eribulin1 / 2Active Not Recruiting1
DB00441Gemcitabine1 / 2Completed1
DB12257Platinum1 / 2Completed1
DB00877Sirolimus1 / 2Completed1
DB12218AZD-53632Recruiting1
DB08916Afatinib2Recruiting1
DB11967Binimetinib2Recruiting1
DB12483Copanlisib2Recruiting1
DB08865Crizotinib2Recruiting1
DB08912Dabrafenib2Recruiting1
DB01254Dasatinib2Recruiting1
DB12282Defactinib2Recruiting1
DB12147Erdafitinib2Recruiting1
DB00530Erlotinib2Terminated1
DB11795GSK-26367712Recruiting1
DB11743Ipatasertib2Recruiting1
DB14723Larotrectinib2Recruiting1
DB11740MK-17752Recruiting1
DB09035Nivolumab2Recruiting2
DB09330Osimertinib2Recruiting1
DB09073Palbociclib2Recruiting1
DB09037Pembrolizumab2Recruiting1
DB06366Pertuzumab2Recruiting1
DB11836Sapanisertib2Recruiting2
DB14546Sulfate ion2Recruiting1
DB01268Sunitinib2Recruiting1
DB12108Taselisib2Recruiting1
DB08911Trametinib2Recruiting1
DB00072Trastuzumab2Recruiting1
DB05773Trastuzumab emtansine2Recruiting1
DB00135Tyrosine2Recruiting1
DB13930Ulixertinib2Recruiting1
DB08828Vismodegib2Recruiting1
DB00112Bevacizumab3Active Not Recruiting1
DB14547Chloride ion3Active Not Recruiting1
DB00515Cisplatin3Active Not Recruiting1
DB00441Gemcitabine3Active Not Recruiting1
DB12257Platinum3Active Not Recruiting1